Mirdametinib (PD0325901) Liposomes, Formulation U6-2

Mirdametinib (PD0325901) Liposomes, Formulation U6-2

Seller Gentaur · Catalog number: DLL-0008-1D-25MG

Category product: Business and Industry > Scientific and Laboratory Research

 (0) Reviews
Availability: Available
Price

1314.50 USD*

Size
2.5 mL
Mirdametinib (PD0325901) Liposomes, Formulation U6-2
Mirdametinib (PD0325901) Liposomes, Formulation U6-2

Catalog number: / Size: / Price : USDtest product-price-currency (VAT free)

Inquiry cart
1
Adres Email: | Edit
2
Details of the inquiry
Mirdametinib (PD0325901) Liposomes, Formulation U6-2
Mirdametinib (PD0325901) Liposomes, Formulation U6-2

Catalog number: DLL-0008-1D-25MG / Size: 2.5 mL / Price: 1314.50 USD (VAT free)

3
Inquiry cart
* Net price, excluding transport costs. Contact us to receive the current offer within 24 hours.
Mirdametinib (PD0325901) Liposomes, Formulation U6-2
Ask for price
Availability: Out of stock
Cat: DLL-0008-1A-100MG
Ask for more info: [email protected]
Mirdametinib (PD0325901) Liposomes, Formulation U6-2
Ask for price
Availability: Out of stock
Cat: DLL-0008-1A-10MG
Ask for more info: [email protected]
Mirdametinib (PD0325901) Liposomes, Formulation U6-2
Ask for price
Availability: Out of stock
Cat: DLL-0008-1B-100MG
Ask for more info: [email protected]
Mirdametinib (PD0325901) Liposomes, Formulation U6-2
Ask for price
Availability: Out of stock
Cat: DLL-0008-1A-100MG
Ask for more info: [email protected]
Tanespimycin (17-AAG) Liposomes, Formulation XT28.1
Ask for price
Availability: Out of stock
Cat: DLL-0011-2ML
Ask for more info: [email protected]
  • Specifications: 10.0 mg/mL (± ~5%)
  • Notes: MAPK/ERK pathway
  • Additional information: 292 mM sucrose, 0.5% DPBS (1X)